Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 1
2000 1
2005 1
2006 5
2007 1
2008 1
2009 6
2010 4
2011 4
2012 4
2013 5
2014 5
2015 12
2016 6
2017 15
2018 22
2019 19
2020 16
2021 15
2022 13
2023 24
2024 15
2025 38
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

214 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Stelkic
Page 1
Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling.
Freed LE, Guilak F, Guo XE, Gray ML, Tranquillo R, Holmes JW, Radisic M, Sefton MV, Kaplan D, Vunjak-Novakovic G. Freed LE, et al. Tissue Eng. 2006 Dec;12(12):3285-305. doi: 10.1089/ten.2006.12.3285. Tissue Eng. 2006. PMID: 17518670 Review.
Holmes offered the perspective of a "reverse paradigm''--the use of tissue constructs in quantitative studies of cell-matrix interactions, cell mechanics, matrix mechanics, and mechanobiology. Milica Radisic discussed biomimetic design of tissue-engineering systems, on the …
Holmes offered the perspective of a "reverse paradigm''--the use of tissue constructs in quantitative studies of cell-matrix interactions, c …
A dermis-on-a-chip model for compound screening.
Abdo D, Zhao Y, Okhovatian S, Jiménez Vargas LF, Wagner KT, Shakeri A, Vosoughi D, Radisic M. Abdo D, et al. Mater Today Bio. 2025 Jul 18;34:102111. doi: 10.1016/j.mtbio.2025.102111. eCollection 2025 Oct. Mater Today Bio. 2025. PMID: 40740248 Free PMC article.
Milicia excelsa (Moraceae) reversed the effects of letrozole-induced aromatase inhibition in rats with polycystic ovary syndrome.
Noubouossie Pouegue J, Mvondo MA. Noubouossie Pouegue J, et al. J Complement Integr Med. 2023 Jan 9;20(2):379-386. doi: 10.1515/jcim-2022-0352. eCollection 2023 Jun 1. J Complement Integr Med. 2023. PMID: 36617954
There is no single drug for the treatment of PCOS and current therapies have significant side effects. This study evaluated the ability of Milica excelsa to improve PCOS symptoms in rats. METHODS: Induction of PCOS was achieved using letrozole (a reversible aromatase inhib …
There is no single drug for the treatment of PCOS and current therapies have significant side effects. This study evaluated the ability of …
Maturation of iPSC-derived cardiomyocytes in a heart-on-a-chip device enables modeling of dilated cardiomyopathy caused by R222Q-SCN5A mutation.
Wauchop M, Rafatian N, Zhao Y, Chen W, Gagliardi M, Massé S, Cox BJ, Lai P, Liang T, Landau S, Protze S, Gao XD, Wang EY, Tung KC, Laksman Z, Lu RXZ, Keller G, Nanthakumar K, Radisic M, Backx PH. Wauchop M, et al. Biomaterials. 2023 Oct;301:122255. doi: 10.1016/j.biomaterials.2023.122255. Epub 2023 Jul 26. Biomaterials. 2023. PMID: 37651922 Free PMC article.
[Women and medical skill--historic view].
Zuskin E, Piasek M, Piasek G, Sarić M, Mustajbegović J, Susec T. Zuskin E, et al. Lijec Vjesn. 2006 Mar-Apr;128(3-4):114-21. Lijec Vjesn. 2006. PMID: 16808102 Croatian.
In Croatia the first woman medical doctor was Milica Sviglin Cavov, who graduated from the Medical School in Zurich in 1893, but was not allowed to work in the home country. ...
In Croatia the first woman medical doctor was Milica Sviglin Cavov, who graduated from the Medical School in Zurich in 1893, but was …
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease.
Jessen F, Arbizu J, Boada M, Balasa M, Bennys K, Boban M, Bürger K, Chincarini A, Cagnin A, De Deyn PP, Düzel E, Engelborghs S, Ewers M, Exalto LG, van der Flier WM, Fortea J, Frederiksen KS, Frisoni GB, Frölich L, Garza-Martinez AJ, Grimmer T, Hanseeuw B, Hort J, Ivanoiu A, Kehoe PG, Kennelly SP, Kern S, Klöppel S, Krajčovičová L, Kramberger MG, McGuinness B, Mecocci P, Oberstein TJ, Ousset PJ, Paquet C, Perneczky R, Piazza F, Plantone D, Rainero I, Sacco G, Salmon E, Santana I, Scarmeas N, Schneider A, Schott JM, Solje E, Stefanova E, Stögmann E, Strauss M, Sutovsky S, Waldemar G, Winblad B. Jessen F, et al. J Prev Alzheimers Dis. 2025 Sep;12(8):100259. doi: 10.1016/j.tjpad.2025.100259. Epub 2025 Jul 9. J Prev Alzheimers Dis. 2025. PMID: 40640062 Free PMC article. No abstract available.
214 results